Article ; Online: Improving access to gene therapy for rare diseases.
2024 Volume 17, Issue 6
Abstract: Effective gene therapy approaches have been developed for many rare diseases, including inborn errors of immunity and metabolism, haemoglobinopathies and inherited blindness. Despite successful pre-clinical and clinical results, these gene therapies are ... ...
Abstract | Effective gene therapy approaches have been developed for many rare diseases, including inborn errors of immunity and metabolism, haemoglobinopathies and inherited blindness. Despite successful pre-clinical and clinical results, these gene therapies are not widely available, primarily for non-medical reasons. Lack of commercial interest in therapies for ultra-rare diseases, costs of development and complex manufacturing processes required for advanced therapy medicinal products (ATMPs) are some of the main problems that are restricting access. The complexities and costs of navigating the regulatory environments in different jurisdictions for treatments that affect small numbers of patients is a problem unique to ATMPS for rare and ultra-rare diseases. In this Perspective, we outline some of the challenges and potential solutions that, we hope, will improve access to gene therapy for rare diseases. |
---|---|
MeSH term(s) | Humans ; Rare Diseases/genetics ; Rare Diseases/therapy ; Genetic Therapy/methods |
Language | English |
Publishing date | 2024-04-19 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2451104-3 |
ISSN | 1754-8411 ; 1754-8403 |
ISSN (online) | 1754-8411 |
ISSN | 1754-8403 |
DOI | 10.1242/dmm.050623 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.